Masterclass Certificate in Drug Targeting: Scientific Frontiers
-- ViewingNowThe Masterclass Certificate in Drug Targeting: Scientific Frontiers is a comprehensive course that equips learners with essential skills in drug targeting, a critical area in pharmaceutical and biotechnology industries. This course emphasizes the importance of understanding the mechanisms of drug action and resistance, enabling learners to contribute to the development of effective therapeutic strategies.
6,873+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ๅ ณไบ่ฟ้จ่ฏพ็จ
100%ๅจ็บฟ
้ๆถ้ๅฐๅญฆไน
ๅฏๅไบซ็่ฏไนฆ
ๆทปๅ ๅฐๆจ็LinkedInไธชไบบ่ตๆ
2ไธชๆๅฎๆ
ๆฏๅจ2-3ๅฐๆถ
้ๆถๅผๅง
ๆ ็ญๅพ ๆ
่ฏพ็จ่ฏฆๆ
โข Molecular Basis of Drug Targeting: Introduction to drug targeting, including the molecular basis of drug-target interactions, target selection, and validation.
โข Pharmacokinetics and Pharmacodynamics: Understanding the principles of pharmacokinetics and pharmacodynamics, and their impact on drug targeting.
โข Computational Approaches to Drug Targeting: Exploration of computational methods, including structure-based drug design, molecular dynamics simulations, and machine learning algorithms, for drug targeting.
โข Emerging Drug Targets: Investigation of novel drug targets, including those in oncology, neuroscience, and infectious diseases, and the challenges associated with their development.
โข Antibody-Based Drug Targeting: Overview of antibody-based drug targeting strategies, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates.
โข Cell-Based Drug Targeting: Examination of cell-based drug targeting approaches, including nanoparticle-based delivery systems and cell-penetrating peptides.
โข Clinical Translation of Drug Targeting: Discussion of the challenges and opportunities in translating drug targeting strategies from preclinical to clinical settings.
โข Regulatory and Ethical Considerations in Drug Targeting: Consideration of regulatory and ethical issues in drug targeting, including intellectual property, data sharing, and patient safety.
่ไธ้่ทฏ
ๅ ฅๅญฆ่ฆๆฑ
- ๅฏนไธป้ข็ๅบๆฌ็่งฃ
- ่ฑ่ฏญ่ฏญ่จ่ฝๅ
- ่ฎก็ฎๆบๅไบ่็ฝ่ฎฟ้ฎ
- ๅบๆฌ่ฎก็ฎๆบๆ่ฝ
- ๅฎๆ่ฏพ็จ็ๅฅ็ฎ็ฒพ็ฅ
ๆ ้ไบๅ ็ๆญฃๅผ่ตๆ ผใ่ฏพ็จ่ฎพ่ฎกๆณจ้ๅฏ่ฎฟ้ฎๆงใ
่ฏพ็จ็ถๆ
ๆฌ่ฏพ็จไธบ่ไธๅๅฑๆไพๅฎ็จ็็ฅ่ฏๅๆ่ฝใๅฎๆฏ๏ผ
- ๆช็ป่ฎคๅฏๆบๆ่ฎค่ฏ
- ๆช็ปๆๆๆบๆ็็ฎก
- ๅฏนๆญฃๅผ่ตๆ ผ็่กฅๅ
ๆๅๅฎๆ่ฏพ็จๅ๏ผๆจๅฐ่ทๅพ็ปไธ่ฏไนฆใ
ไธบไปไนไบบไปฌ้ๆฉๆไปฌไฝไธบ่ไธๅๅฑ
ๆญฃๅจๅ ่ฝฝ่ฏ่ฎบ...
ๅธธ่ง้ฎ้ข
่ฏพ็จ่ดน็จ
- ๆฏๅจ3-4ๅฐๆถ
- ๆๅ่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๆฏๅจ2-3ๅฐๆถ
- ๅธธ่ง่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๅฎๆด่ฏพ็จ่ฎฟ้ฎ
- ๆฐๅญ่ฏไนฆ
- ่ฏพ็จๆๆ
่ทๅ่ฏพ็จไฟกๆฏ
่ทๅพ่ไธ่ฏไนฆ
